Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 3/20 | 0.35 |
| ▸ | NOX1 | Q9Y5S8 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | HTR2C | P28335 | 2/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 4/20 | 0.32 |
| ▸ | MAPT | P10636 | 4/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29625245 | 0.80 | SNCA (0.50) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| SCHEMBL64975 | 0.80 | SNCA (0.50) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| SCHEMBL29600380 | 0.80 | SNCA (0.50) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| Iodide SCHEMBL1206518 | 0.78 | SNCA (0.48) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| Hydrochloric Acid SCHEMBL12470954 | 0.78 | SNCA (0.48) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| Hydrochloric Acid SCHEMBL31175976 | 0.78 | SNCA (0.48) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| Iodide SCHEMBL28955143 | 0.78 | SNCA (0.48) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| Iodide SCHEMBL29850697 | 0.78 | SNCA (0.48) | SNCANOX1MEN1KMT2AL3MBTL1 | |
| SCHEMBL9243182 | 0.76 | NOX1 (0.33) | SNCANOX1L3MBTL1 | |
| SCHEMBL4255828 | 0.74 | MEN1 (0.38) | SNCANOX1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2025-06-10 | — | — | US | disclosed |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2024-07-25 | — | — | US | disclosed |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2024-04-09 | — | — | US | disclosed |
| US-11344558-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2022-05-31 | — | — | US | disclosed |
| US-20220152038-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2022-05-19 | — | — | US | disclosed |
| US-20190151329-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2019-05-23 | — | — | US | disclosed |
| US-10188658-B2 | Therapeutic use of diaminophenothiazines | WISTA LABORATORIES LTD. (SG) | 2019-01-29 | — | — | US | disclosed |
| US-20160051559-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2016-02-25 | — | — | US | disclosed |
| US-20160030444-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2016-02-04 | — | — | US | disclosed |
| US-8710051-B2 | 3,7-diamino-10H-phenothiazine salts and their use | Wis Ta Laboratories Ltd. (SG) | 2014-04-29 | — | — | US | disclosed |
| US-20110118242-A1 | 3,7-DIAMINO-10H-PHINOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. | 2011-05-19 | — | — | US | disclosed |
| US-7888350-B2 | 3,7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2011-02-15 | — | — | US | disclosed |
| US-20100290986-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | Wis Ta Laboratories Ltd. | 2010-11-18 | — | — | US | disclosed |
| EP-2013191-B1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LAB LTD (SG) | 2010-08-18 | — | — | EP | disclosed |
| EP-2205245-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | Wista Laboratories Ltd. (SG) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009044127-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (GB) | 2009-04-09 | — | — | WO | disclosed |
| US-20090054419-A1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. | 2009-02-26 | — | — | US | disclosed |
| EP-2013191-A2 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | Wista Laboratories Ltd. (SG) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007110627-A2 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2007-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 673/4885NOX1 187/4885MEN1 2704/4885 |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | SNCA 467/4885NOX1 347/4885MEN1 3093/4885 |
| US-20110118242-A1 | 3,7-DIAMINO-10H-PHINOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 1937/4885NOX1 450/4885MEN1 271/4885 |
| US-20160051559-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 673/4885NOX1 187/4885MEN1 2704/4885 |
| US-20100290986-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | QDPR, DDO, HNMT | SNCA 447/4885NOX1 2161/4885MEN1 370/4885 |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | SNCA 673/4885NOX1 187/4885MEN1 2704/4885 |
| US-10188658-B2 | Therapeutic use of diaminophenothiazines | QDPR, DDO, HNMT | SNCA 430/4885NOX1 2397/4885MEN1 286/4885 |
| US-20160030444-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | QDPR, DDO, HNMT | SNCA 398/4885NOX1 2264/4885MEN1 238/4885 |
| US-11344558-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | SNCA 673/4885NOX1 187/4885MEN1 2704/4885 |
| US-20220152038-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 437/4885NOX1 255/4885MEN1 2392/4885 |
| US-20190151329-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | QDPR, DDO, HNMT | SNCA 398/4885NOX1 2264/4885MEN1 238/4885 |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 467/4885NOX1 347/4885MEN1 3093/4885 |
| US-20090054419-A1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, HTT | SNCA 1049/4885NOX1 490/4885MEN1 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.